BRR OpCo’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $8.28M | Buy |
25,611
+2,444
| +11% | +$774K | 1.02% | 15 |
|
|
2022
Q2 | $7.51M | Sell |
23,167
-161
| -0.7% | -$48.3K | 0.89% | 16 |
|
|
2022
Q1 | $6.68M | Sell |
23,328
-61
| -0.3% | -$15.7K | 0.71% | 15 |
|
|
2021
Q4 | $6.46M | Sell |
23,389
-305
| -1% | -$77.3K | 0.7% | 18 |
|
|
2021
Q3 | $5.47M | Sell |
23,694
-1,676
| -7% | -$414K | 0.62% | 20 |
|
|
2021
Q2 | $5.82M | Sell |
25,370
-870
| -3% | -$175K | 0.64% | 18 |
|
|
2021
Q1 | $4.9M | Sell |
26,240
-489
| -2% | -$95.7K | 0.59% | 17 |
|
|
2020
Q4 | $4.51M | Buy |
26,729
+1,958
| +8% | +$292K | 0.66% | 18 |
|
|
2020
Q3 | $3.67M | Sell |
24,771
-200
| -0.8% | -$31K | 0.61% | 17 |
|
|
2020
Q2 | $4.1M | Buy |
24,971
+1,714
| +7% | +$263K | 0.71% | 16 |
|
|
2020
Q1 | $3.23M | Buy |
23,257
+4
| +0% | +$550 | 0.62% | 19 |
|
|
2019
Q4 | $3.06M | Buy |
23,253
+908
| +4% | +$105K | 0.43% | 23 |
|
|
2019
Q3 | $2.5M | Buy |
22,345
+20
| +0.1% | +$2.23K | 0.4% | 26 |
|
|
2019
Q2 | $2.47M | Buy |
22,325
+2,173
| +11% | +$256K | 0.4% | 25 |
|
|
2019
Q1 | $2.62M | Buy |
20,152
+6,770
| +51% | +$823K | 0.45% | 24 |
|
|
2018
Q4 | $1.55M | Sell |
13,382
-1,297
| -9% | -$145K | 0.32% | 30 |
|
|
2018
Q3 | $1.57M | Buy |
14,679
+978
| +7% | +$97.8K | 0.31% | 27 |
|
|
2018
Q2 | $1.17M | Sell |
13,701
-270
| -2% | -$22.2K | 0.32% | 33 |
|
|
2018
Q1 | $1.08M | Sell |
13,971
-129
| -0.9% | -$10.4K | 0.3% | 34 |
|
|
2017
Q4 | $1.19M | Buy |
14,100
+86
| +0.6% | +$7.32K | 0.33% | 33 |
|
|
2017
Q3 | $1.2M | Sell |
14,014
-414
| -3% | -$34K | 0.37% | 37 |
|
|
2017
Q2 | $1.19M | Sell |
14,428
-225
| -2% | -$18.4K | 0.39% | 32 |
|
|
2017
Q1 | $1.23M | Sell |
14,653
-950
| -6% | -$76.1K | 0.4% | 31 |
|
|
2016
Q4 | $1.15M | Sell |
15,603
-10,212
| -40% | -$761K | 0.37% | 33 |
|
|
2016
Q3 | $2.07M | Sell |
25,815
-324
| -1% | -$25.9K | 0.68% | 21 |
|
|
2016
Q2 | $2.06M | Sell |
26,139
-982
| -4% | -$73.9K | 0.69% | 21 |
|
|
2016
Q1 | $1.95M | Sell |
27,121
-35
| -0.1% | -$2.65K | 0.69% | 21 |
|
|
2015
Q4 | $2.29M | Buy |
27,156
+121
| +0.4% | +$10K | 0.84% | 22 |
|
|
2015
Q3 | $2.26M | Sell |
27,035
-5
| -0% | -$422 | 0.97% | 19 |
|
|
2015
Q2 | $2.26M | Sell |
27,040
-8,250
| -23% | -$629K | 0.92% | 20 |
|
|
2015
Q1 | $2.56M | Sell |
35,290
-909
| -3% | -$64.7K | 1.05% | 16 |
|
|
2014
Q4 | $2.5M | Sell |
36,199
-866
| -2% | -$58.5K | 0.99% | 15 |
|
|
2014
Q3 | $2.4M | Sell |
37,065
-1,008
| -3% | -$63.8K | 0.99% | 16 |
|
|
2014
Q2 | $2.34M | Sell |
38,073
-683
| -2% | -$40.8K | 0.98% | 16 |
|
|
2014
Q1 | $2.28M | Buy |
38,756
+519
| +1% | +$29K | 1% | 15 |
|
|
2013
Q4 | $1.95M | Sell |
38,237
-334
| -0.9% | -$16.7K | 0.84% | 19 |
|
|
2013
Q3 | $1.94M | Sell |
38,571
-475
| -1% | -$24.9K | 0.91% | 17 |
|
|
2013
Q2 | $1.92M | Buy |
+39,046
| New | +$2.12M | 0.92% | 16 |
|
Other funds holding LLY
BRR OpCo's LLY Position: Q3 2022 in Review
BRR OpCo increased its Eli Lilly (LLY) stake by 11% in Q3 2022, buying an estimated $774K and bringing the position to 25,611 shares worth $8.28M. The position accounts for 1.02% of the portfolio, ranked #15.
BRR OpCo first reported a position in LLY in Q2 2013 and has held it in 38 quarters since. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.
- BRR OpCo held 25,611 shares of Eli Lilly worth $8.28M as of Q3 2022.
- BRR OpCo bought 2,444 Eli Lilly shares in Q3 2022, an estimated $774K.
- Eli Lilly made up 1.02% of BRR OpCo's portfolio in Q3 2022, its #15 holding.
- BRR OpCo first reported a position in Eli Lilly in Q2 2013 and has held it in 38 quarters since.
- 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.
Based on BRR OpCo's 13F filing for Q3 2022, filed 8 Nov 2022.